1. Home
  2. LEGN vs MNSO Comparison

LEGN vs MNSO Comparison

Compare LEGN & MNSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • MNSO
  • Stock Information
  • Founded
  • LEGN 2014
  • MNSO 2013
  • Country
  • LEGN United States
  • MNSO China
  • Employees
  • LEGN N/A
  • MNSO N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • MNSO Department/Specialty Retail Stores
  • Sector
  • LEGN Health Care
  • MNSO Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • MNSO Nasdaq
  • Market Cap
  • LEGN 7.0B
  • MNSO 6.5B
  • IPO Year
  • LEGN 2020
  • MNSO 2020
  • Fundamental
  • Price
  • LEGN $31.78
  • MNSO $19.68
  • Analyst Decision
  • LEGN Strong Buy
  • MNSO Buy
  • Analyst Count
  • LEGN 13
  • MNSO 4
  • Target Price
  • LEGN $79.42
  • MNSO $24.40
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • MNSO 924.0K
  • Earning Date
  • LEGN 05-13-2025
  • MNSO 05-16-2025
  • Dividend Yield
  • LEGN N/A
  • MNSO 3.00%
  • EPS Growth
  • LEGN N/A
  • MNSO 16.73
  • EPS
  • LEGN N/A
  • MNSO 1.15
  • Revenue
  • LEGN $627,241,000.00
  • MNSO $2,328,235,670.00
  • Revenue This Year
  • LEGN $65.96
  • MNSO $25.91
  • Revenue Next Year
  • LEGN $52.55
  • MNSO $18.77
  • P/E Ratio
  • LEGN N/A
  • MNSO $16.09
  • Revenue Growth
  • LEGN 119.97
  • MNSO 22.80
  • 52 Week Low
  • LEGN $29.27
  • MNSO $12.51
  • 52 Week High
  • LEGN $60.87
  • MNSO $27.71
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 41.49
  • MNSO 62.02
  • Support Level
  • LEGN $30.25
  • MNSO $17.52
  • Resistance Level
  • LEGN $35.81
  • MNSO $18.83
  • Average True Range (ATR)
  • LEGN 1.45
  • MNSO 0.58
  • MACD
  • LEGN -0.18
  • MNSO 0.34
  • Stochastic Oscillator
  • LEGN 27.58
  • MNSO 83.80

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About MNSO MINISO Group Holding Limited

MINISO Group Holding Ltd is a retailer offering a variety of design-led lifestyle products. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: